Warfarin Sensitivity Genotyping

In this presentation:

Use of Mayo’s recently introduced warfarin sensitivity genotyping test in the identification of patients at risk of warfarin-associated bleeding is discussed.

Our speaker for this program is Dr. Dennis J. O’Kane, Co-Director of the Nucleotide Polymorphism Laboratory, in the Division of Clinical Biochemistry and Immunology at Mayo Clinic.

View the presentationSend to a colleague

Upon viewing the video, you may obtain a Record of Viewing.

Learn more about Dr. Dennis J. O’Kane.

Learn more about the Division of Clinical Biochemistry & Immunology.

Associated test:

• #89033 Warfarin Sensitivity, Genotype

Additional information:

See Warfarin: Genotyping and improving dosing in the August 2008 issue of Communiqué.

Warfarin genotyping is just one of the tests that Mayo Medical Laboratories offers to identify those patients with abnormal drug metabolism. Testing is also available for the cytochrome P450 polymorphisms:

• #83639 Cytochrome P450 2C19 Genotype
• #83652 Cytochrome P450 2C9 Genotype